0001209191-19-015645.txt : 20190304 0001209191-19-015645.hdr.sgml : 20190304 20190304163148 ACCESSION NUMBER: 0001209191-19-015645 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190304 DATE AS OF CHANGE: 20190304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarriff Scott CENTRAL INDEX KEY: 0001469124 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36306 FILM NUMBER: 19654208 MAIL ADDRESS: STREET 1: 28 TUDOR ROSE TERRACE CITY: MAHWAH STATE: NJ ZIP: 07430 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000827871 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-326-5300 MAIL ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19880120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-01 0 0000827871 EAGLE PHARMACEUTICALS, INC. EGRX 0001469124 Tarriff Scott C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BLVD., SUITE 315 WOODCLIFF LAKE NJ 07677 1 1 1 0 CEO Common Stock 2019-03-01 4 S 0 12000 50.51 D 1537605 D Common Stock 2019-03-01 4 S 0 12428 51.81 D 1525177 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.1615 to $51.0577 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.3201 to $52.2003 inclusive. /s/ Scott Tarriff 2019-03-04